Nordea has completed its review concerning the report published on 20 November 2021 about COVID-19 vaccinations. The conclusion of the review is that it contains statements and references that are not consistent with Nordea’s Code of Conduct and values.
“To ensure high quality of Nordea Markets publications, we are strengthening our editorial procedure, research publication process and compliance guidelines. We will continue to provide our customers with analysis and research with high integrity and relevance,” says Martin Persson, Head of Large Corporates & Institutions at Nordea.
The two writers of the report have been offered to continue at Nordea Markets, but they have decided to leave Nordea.